| scholarly article | Q13442814 |
| P50 | author | Juan B. Rodríguez | Q55762175 |
| P2093 | author name string | Julio A Urbina | |
| Roberto Docampo | |||
| Andrea Montalvetti | |||
| Juan Luis Concepcion | |||
| P2860 | cites work | Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. | Q33694317 |
| Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana | Q34162880 | ||
| Recent developments in the chemotherapy of Chagas disease. | Q34319202 | ||
| Chemotherapy of Chagas disease | Q34541660 | ||
| Specific treatment of Chagas disease: current status and new developments | Q34608380 | ||
| Effects of juvenile hormone on mammalian steroidogenesis | Q41450426 | ||
| Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites | Q41601456 | ||
| Development of a radiometric spot-wash assay for squalene synthase | Q41954359 | ||
| Synthesis and activity of a novel series of 3-biarylquinuclidine squalene synthase inhibitors | Q42555302 | ||
| YM-53601, a novel squalene synthase inhibitor, reduces plasma cholesterol and triglyceride levels in several animal species | Q43264545 | ||
| Bisphosphonates are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase | Q43660559 | ||
| Recombinant squalene synthase. Synthesis of non-head-to-tail isoprenoids in the absence of NADPH. | Q44076633 | ||
| Recombinant squalene synthase. A mechanism for the rearrangement of presqualene diphosphate to squalene | Q44076636 | ||
| Design, synthesis, and biological evaluation of aryloxyethyl thiocyanate derivatives against Trypanosoma cruzi | Q44110808 | ||
| Squalene synthase: steady-state, pre-steady-state, and isotope-trapping studies. | Q55033631 | ||
| Cure of short- and long-term experimental Chagas' disease using D0870 | Q58843324 | ||
| Structure−Activity Relationship of New Growth Inhibitors ofTrypanosomacruzi | Q58866773 | ||
| Trypanosoma (Schizotrypanum) cruzi: terminal oxidases in exponential and stationary growth phase emipastigotes cultured in vitro | Q70406315 | ||
| Modification of the sterol composition of Trypanosoma (Schizotrypanum) cruzi epimastigotes by delta 24(25)-sterol methyl transferase inhibitors and their combinations with ketoconazole | Q70940460 | ||
| Inhibition of squalene synthase in vitro by 3-(biphenyl-4-yl)-quinuclidine | Q71077795 | ||
| Regulation of the cholesterol ester cycle and progesterone synthesis by juvenile hormone in MA-10 Leydig tumor cells | Q72550267 | ||
| 3-Hydroxy-3-methyl-glutaryl-CoA reductase in Trypanosoma (Schizotrypanum) cruzi: subcellular localization and kinetic properties | Q74378292 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Chagas disease | Q649558 |
| Trypanosoma cruzi | Q150162 | ||
| P304 | page(s) | 2047-2050 | |
| P577 | publication date | 2003-06-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Mechanism of action of 4-phenoxyphenoxyethyl thiocyanate (WC-9) against Trypanosoma cruzi, the causative agent of Chagas' disease | |
| P478 | volume | 47 |
| Q38938937 | Activity of Fluorine-Containing Analogues of WC-9 and Structurally Related Analogues against Two Intracellular Parasites: Trypanosoma cruzi and Toxoplasma gondii. |
| Q92610556 | Advances in preclinical approaches to Chagas disease drug discovery |
| Q35660950 | Aryloxyethyl Thiocyanates Are Potent Growth Inhibitors of Trypanosoma cruzi and Toxoplasma gondii. |
| Q36795395 | Cardiac manifestations of parasitic infections part 1: overview and immunopathogenesis. |
| Q37318751 | Design, synthesis and biological evaluation of WC-9 analogs as antiparasitic agents |
| Q38845466 | Detection and treatment of Trypanosoma cruzi: a patent review (2011-2015). |
| Q43276756 | Ergosterol biosynthesis and drug development for Chagas disease |
| Q37254812 | Fluorine-containing aryloxyethyl thiocyanate derivatives are potent inhibitors of Trypanosoma cruzi and Toxoplasma gondii proliferation |
| Q91941849 | Further insights of selenium-containing analogues of WC-9 against Trypanosoma cruzi |
| Q27678389 | Head-to-Head Prenyl Tranferases: Anti-Infective Drug Targets |
| Q37612993 | In Vitro and In Vivo Activities of Sulfur-Containing Linear Bisphosphonates against Apicomplexan Parasites |
| Q35125554 | In vitro and in vivo activities of E5700 and ER-119884, two novel orally active squalene synthase inhibitors, against Trypanosoma cruzi |
| Q79416088 | Inhibitory effect of umbelliferone aminoalkyl derivatives on oxidosqualene cyclases from S. cerevisiae, T. cruzi, P. carinii, H. sapiens, and A. thaliana: a structure-activity study |
| Q37992089 | New antibacterials for the treatment of toxoplasmosis; a patent review |
| Q28554785 | Quantitative Laser Biospeckle Method for the Evaluation of the Activity of Trypanosoma cruzi Using VDRL Plates and Digital Analysis |
| Q27683611 | Squalene synthase as a target for Chagas disease therapeutics |
| Q36580508 | Synthesis and biological evaluation of 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase |
| Q34764622 | Synthesis and biological evaluation of new 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase. |
| Q33290749 | Synthesis, Cruzain docking, and in vitro studies of aryl-4-oxothiazolylhydrazones against Trypanosoma cruzi |
| Q38974228 | Synthetic Medicinal Chemistry in Chagas' Disease: Compounds at The Final Stage of "Hit-To-Lead" Phase |
| Q35022297 | Toxoplasma gondii relies on both host and parasite isoprenoids and can be rendered sensitive to atorvastatin |
Search more.